University of Illinois Cancer Center at Chicago SC — Chicago, Illinois

University of Illinois Cancer Center at Chicago SC is a clinical research site located in Chicago, Illinois, United States 60612.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

University of Illinois Cancer Center at Chicago SC has participated in 1 clinical trials.

Therapeutic areas: Small Cell Lung Cancer, Gastric Adenocarcinoma, Esophageal Adenocarcinoma.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Illinois Cancer Center at Chicago SC?

University of Illinois Cancer Center at Chicago SC has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Illinois Cancer Center at Chicago SC conducted?

University of Illinois Cancer Center at Chicago SC has 1 clinical trials on record. Their work covers Small Cell Lung Cancer, Gastric Adenocarcinoma, Esophageal Adenocarcinoma.

Is University of Illinois Cancer Center at Chicago SC accredited by Crixeo Health?

University of Illinois Cancer Center at Chicago SC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Illinois Cancer Center at Chicago SC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.